Portola Pharmaceuticals to Present at the Credit Suisse 25th Annual Healthcare Conference
02 Novembre 2016 - 1:00PM
Portola Pharmaceuticals (Nasdaq:PTLA) today announced that Bill
Lis, chief executive officer, will present at the Credit Suisse
24th Annual Healthcare Conference on Tuesday, November 8, at 1:00
p.m. Mountain Standard Time in Scottsdale, Ariz.
The presentation will be webcast live and available for replay
from Portola's website at www.portola.com in the Investor Relations
section.
About Portola Pharmaceuticals, Inc.Portola
Pharmaceuticals is a biopharmaceutical company developing
product candidates that could significantly advance the fields of
thrombosis and other hematologic diseases. The Company is advancing
three programs, including betrixaban, an oral, once-daily Factor Xa
inhibitor; AndexXa™ (andexanet alfa), a recombinant protein
designed to reverse the anticoagulant effect in patients treated
with an oral or injectable Factor Xa inhibitor; and cerdulatinib, a
Syk/JAK inhibitor in development to treat hematologic cancers.
Portola's partnered program is focused on developing selective Syk
inhibitors for inflammatory conditions. For more information,
visit www.portola.com and follow the Company on Twitter
@Portola_Pharma.
Investor Contact:
Ana Kapor
Portola Pharmaceuticals
ir@portola.com
Media Contact:
Julie Normart
W2O Group
jnormart@w2ogroup.com
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Portola Pharmaceuticals (NASDAQ:PTLA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
Real-Time news about Portola Pharmaceuticals Inc (NASDAQ): 0 recent articles
Plus d'articles sur